MedX Health Corp. announced a Memorandum of Understanding ("MOU") and the launch of a new commercialization pilot project with Health Partners (OH) Limited, a well-respected, privately- owned corporate health, treatment and primary care services company in the United Kingdom. Serving a
broad client base comprising corporates, government agencies, insurers, health trusts, pension funds and individuals, Health Partners ("HP") employs 700+ people with telehealth, mobile and on-site operations across the UK and the Republic of Ireland. The pilot will span three to six months and involve an estimated 600 patients across two of HP's sites. Upon the successful completion of the pilot, the MedX DermSecure® Screening Platform will be made available to Health Partners' two million-plus patients. The agreement is the latest initiative in MedX's global commercialization strategy and follows pilots recently launched across the Europe and Middle East region. In addition to expanding its DermSecure® Screening Platform network globally, MedX has focused on building a presence in multiple market verticals such as pharmacies, medical clinics, building hubs, medical scanning
clinics, mobile and remote medical practices, as well as esthetics and skincare clinics. The partnership with Health Partners represents MedX's expansion into a new vertical; occupational health and wellbeing services. Health Partners will pilot MedX's high-definition image-capture technology, SIAscopy®, and its secure, cloud- based patient management system, DermSecure®, which transmits and stores patient data throughout the assessment process. MedX's SIAscopy® is the only technology available that captures five high-resolution images of suspicious moles, lesions and skin conditions, including four spectrophotometric images taken 2mm below the skin's surface. This technology provides detailed patient scans, which a certified dermatologist can virtually assess within 72 hours.